Cargando…
Aspirin Use Is Not Associated with the Risk of Metachronous Gastric Cancer in Patients without Helicobacter pylori Infection
Introduction: Helicobacter pylori (H. pylori) eradication can prevent metachronous gastric cancer (MGC) after the performance of an endoscopic resection for early gastric cancer (EGC). However, 50% of infections persist after eradication, and the identification of MGC protective factors is important...
Autores principales: | Kim, Ji Eun, Kim, Tae Jun, Lee, Hyuk, Lee, Yeong Chan, Chung, Hwe Hoon, Min, Yang Won, Min, Byung-Hoon, Lee, Jun Haeng, Kim, Jae J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745470/ https://www.ncbi.nlm.nih.gov/pubmed/35011936 http://dx.doi.org/10.3390/jcm11010193 |
Ejemplares similares
-
Statin Use Decreases the Risk of Metachronous Gastric Cancer in Patients without Helicobacter pylori Infection
por: Kwon, Tae Jin, et al.
Publicado: (2021) -
Association between Helicobacter pylori status and metachronous gastric cancer after endoscopic resection
por: Kim, Sung Bum, et al.
Publicado: (2016) -
Helicobacter pylori Eradication Reduces the Metachronous Recurrence of Gastric Neoplasms by Attenuating the Precancerous Process
por: Jung, Da Hyun, et al.
Publicado: (2015) -
Helicobacter pylori is associated with dyslipidemia but not with other risk factors of cardiovascular disease
por: Kim, Tae Jun, et al.
Publicado: (2016) -
Long-Term Effects of Helicobacter pylori Eradication on Metachronous Gastric Cancer Development
por: Han, Seung Jun, et al.
Publicado: (2018)